Compare Novo Nordisk A/S (NVO) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Workday Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Workday Inc trades at $141 (market cap $36.36B). The key difference: Novo Nordisk A/S is far larger — about 6.1× Workday Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Workday Inc pays none. Which is the better fit depends on your goals.
| NVO | WDAY | |
|---|---|---|
Market Cap | $220.53B | $36.36B |
Sector | Health | Technology |
52-Week High | $71.70 | $247.69 |
52-Week Low | $35.29 | $112.55 |
Enterprise Value | $239.49B | $35.81B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
